Schwameis Richard

5PUBLICATIONS
13CO-AUTHORS
Social epidemiologyOncology and carcinogenesis not elsewhere classifiedInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 17, 2023
An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app.

Thomas Gaillard, Richard Schwameis, Enora Laas-Faron

|Feb 05, 2022
There is no role for hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.

Richard Schwameis, Luis Chiva, Philipp Harter

|Nov 13, 2020
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer.

Thomas Bartl, Christine Bekos, Magdalena Postl

|Aug 02, 2019
Prognostic value of serum creatine level in patients with vulvar cancer.

Richard Schwameis, Magdalena Postl, Christine Bekos

|Feb 10, 2019
The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.

Nina Poetsch, Alina Sturdza, Stefanie Aust

Pageof 1

Frequent Collaborators

2 joint publications

Christoph Grimm

2 joint publications

Reinthaller Alexander

1 joint publications

Nina Poetsch

1 joint publications

Veronika Seebacher